Trial intelligence / Profile preview

Ondansetron vs Habitual Practice for Vomiting in Children

NCT04318847Phase 4Unknown

Start
Oct 2021
Primary completion
Apr 2023
Modality
Small Molecules
01

Overview

Phase 4, randomised, open-label trial of ondansetron in Vomiting and dehydration (2 arms). Primary endpoint: Percentage of children who return to medical/pediatric consultation for the same episode at 24 months. Status: unknown.

02

Drugs

ondansetron
03

Conditions

Vomitingdehydration

Beyond the preview

Go deeper on NCT04318847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04318847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call